These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 36015197)

  • 1. Structural and Functional Analysis of CEX Fractions Collected from a Novel Avastin
    Gurel B; Berksoz M; Capkin E; Parlar A; Pala MC; Ozkan A; Capan Y; Daglikoca DE; Yuce M
    Pharmaceutics; 2022 Jul; 14(8):. PubMed ID: 36015197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Similarity demonstrated between isolated charge variants of MB02, a biosimilar of bevacizumab, and Avastin® following extended physicochemical and functional characterization.
    Ruppen I; Beydon ME; Solís C; Sacristán D; Vandenheede I; Ortiz A; Sandra K; Adhikary L
    Biologicals; 2021 Sep; 73():41-56. PubMed ID: 34593306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Similarity demonstrated between isolated charge variants of MB02, a biosimilar of bevacizumab, and Avastin® following extended physicochemical and functional characterization.
    Ruppen I; Beydon ME; Solís C; Sacristán D; Vandenheede I; Ortiz A; Sandra K; Adhikary L
    Biologicals; 2022 Jun; 77():1-15. PubMed ID: 35667958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Method Development and Qualification of pH-Based CEX UPLC Method for Monoclonal Antibodies.
    Bhatt M; Alok A; Kulkarni BB
    BioTech (Basel); 2022 Jun; 11(2):. PubMed ID: 35822792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LC-MS based case-by-case analysis of the impact of acidic and basic charge variants of bevacizumab on stability and biological activity.
    Singh SK; Kumar D; Malani H; Rathore AS
    Sci Rep; 2021 Jan; 11(1):2487. PubMed ID: 33514790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fractionated charge variants of biosimilars: A review of separation methods, structural and functional analysis.
    Yüce M; Sert F; Torabfam M; Parlar A; Gürel B; Çakır N; Dağlıkoca DE; Khan MA; Çapan Y
    Anal Chim Acta; 2021 Apr; 1152():238189. PubMed ID: 33648647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physicochemical and functional comparability between the proposed biosimilar rituximab GP2013 and originator rituximab.
    Visser J; Feuerstein I; Stangler T; Schmiederer T; Fritsch C; Schiestl M
    BioDrugs; 2013 Oct; 27(5):495-507. PubMed ID: 23649935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Charge Variants of an Avastin Biosimilar Isolation, Characterization, In Vitro Properties and Pharmacokinetics in Rat.
    Zhao YY; Wang N; Liu WH; Tao WJ; Liu LL; Shen ZD
    PLoS One; 2016; 11(3):e0151874. PubMed ID: 26987122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation and characterization of charge variants of infliximab biosimilar HS626.
    Yuan JJ; Gao D; Hu F; Shi Y; Wu ZH; Hu CQ; Huang XD; Fang WJ; Zhang HT; Wang HB
    J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Jan; 1162():122485. PubMed ID: 33360415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of structural and functional similarity of biosimilar products: Bevacizumab as a case study.
    Bhattacharya S; Rathore AS
    J Chromatogr B Analyt Technol Biomed Life Sci; 2023 Sep; 1229():123896. PubMed ID: 37776677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of therapeutic proteins by cation exchange chromatography-mass spectrometry and top-down analysis.
    Shi RL; Xiao G; Dillon TM; Ricci MS; Bondarenko PV
    MAbs; 2020; 12(1):1739825. PubMed ID: 32292112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid comparison of a candidate biosimilar to an innovator monoclonal antibody with advanced liquid chromatography and mass spectrometry technologies.
    Xie H; Chakraborty A; Ahn J; Yu YQ; Dakshinamoorthy DP; Gilar M; Chen W; Skilton SJ; Mazzeo JR
    MAbs; 2010; 2(4):379-94. PubMed ID: 20458189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Charge variant analysis of proposed biosimilar to Trastuzumab.
    Dakshinamurthy P; Mukunda P; Prasad Kodaganti B; Shenoy BR; Natarajan B; Maliwalave A; Halan V; Murugesan S; Maity S
    Biologicals; 2017 Mar; 46():46-56. PubMed ID: 28087106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-throughput multiplex analysis of mAb aggregates and charge variants by automated two-dimensional size exclusion-cation exchange chromatography coupled to mass spectrometry.
    Lambiase G; Inman SE; Muroni M; Lindo V; Dickman MJ; James DC
    J Chromatogr A; 2022 May; 1670():462944. PubMed ID: 35344792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-terminal lysine clipping of IgG1: impact on binding to human FcγRIIIa and neonatal Fc receptors.
    Faid V; Leblanc Y; Berger M; Seifert A; Bihoreau N; Chevreux G
    Eur J Pharm Sci; 2021 Apr; 159():105730. PubMed ID: 33493670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of charge variants, including post-translational modifications and proteoforms, of bispecific antigen-binding protein by cation-exchange chromatography coupled to native mass spectrometry.
    Shah A; Cui W; Harrahy J; Ivanov AR
    Talanta; 2024 Jan; 266(Pt 1):125062. PubMed ID: 37566926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Titer and charge-based heterogeneity multiattribute monitoring of mAbs in cell culture harvest using 2D ProA CEX MS.
    Sarin D; Kumar S; Rathore AS
    Talanta; 2024 Aug; 276():126232. PubMed ID: 38749159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Online Two-Dimensional Approach to Characterizing the Charge-Based Heterogeneity of Recombinant Monoclonal Antibodies Using a 2D-CEX-AEX-MS Workflow.
    Kumar S; Peruri V; Rathore AS
    J Am Soc Mass Spectrom; 2023 Dec; 34(12):2801-2810. PubMed ID: 37994779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Online Collision-Induced Unfolding of Therapeutic Monoclonal Antibody Glyco-Variants through Direct Hyphenation of Cation Exchange Chromatography with Native Ion Mobility-Mass Spectrometry.
    van Schaick G; Domínguez-Vega E; Castel J; Wuhrer M; Hernandez-Alba O; Cianférani S
    Anal Chem; 2023 Feb; 95(8):3932-3939. PubMed ID: 36791123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elucidation of degradants in acidic peak of cation exchange chromatography in an IgG1 monoclonal antibody formed on long-term storage in a liquid formulation.
    Gandhi S; Ren D; Xiao G; Bondarenko P; Sloey C; Ricci MS; Krishnan S
    Pharm Res; 2012 Jan; 29(1):209-24. PubMed ID: 21845507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.